{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:01:16Z","timestamp":1790791276725,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cardfail.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T11:59:40Z","timestamp":1624276780000},"page":"1348-1358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Management of Cardiac Sarcoidosis Using Mycophenolate Mofetil as a Steroid-Sparing Agent"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-7464","authenticated-orcid":false,"given":"Jan M.","family":"Griffin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0728-2365","authenticated-orcid":false,"given":"Jessica","family":"Chasler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L.","family":"Wand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Nikolhaus","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari","family":"Tandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chrispin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-8209","authenticated-orcid":false,"given":"Edward S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-8008","authenticated-orcid":false,"given":"Nisha A.","family":"Gilotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2021.06.010_bib0001","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.chest.2017.11.030","article-title":"The pathogenesis of pulmonary sarcoidosis and implications for treatment","volume":"153","author":"Patterson","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0002","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0003","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1749-6632.1986.tb18549.x","article-title":"Longitudinal study of c sarcoidosis with low-dose maintenance corticosteroid therapy: complications and outcomes","author":"Johns","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0004","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0005","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0006","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00004728-200209000-00017","article-title":"Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast enhanced, and cine magnetic resonance imaging: initial results of a prospective study","volume":"26","author":"Vignaux","year":"2002","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0007","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0008","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1440-1827.1993.tb01148.x","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathologica Japonica"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0009","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0010","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0011","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"35","author":"Lynch","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0012","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","article-title":"Long-term adverse cardiac outcomes in patients with sarcoidosis","volume":"76","author":"Yafasova","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0013","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1183\/09031936.06.00105805","article-title":"Corticosteroid treatment in sarcoidosis","volume":"28","author":"Grutters","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0014","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000345596","article-title":"Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study","volume":"86","author":"Brill","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0016","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.rmed.2014.09.013","article-title":"Efficacy of mycophenolate mofetil in sarcoidosis","volume":"108","author":"Hamzeh","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0017","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1212\/WNL.0000000000003431","article-title":"Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil","volume":"87","author":"Bitoun","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0018","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1212\/WNL.0b013e318212aafb","article-title":"Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy","volume":"76","author":"Androdias","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0019","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.17996\/anc.17-00029","article-title":"Japanese guidelines for cardiac sarcoidosis","volume":"3","author":"Yoshinaga","year":"2017","journal-title":"Ann Nuclear Cardiol"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nuclear Cardiol"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0022","unstructured":"Terasaki. CF. Guidelines for the diagnosis and treatment of cardiac sarcoidosis. Published on February 24, 2017 [in Japanese]. The Japanese Circulation Society (JCS). 2017. Available at: http: \/\/www. j-circ. or. jp\/guideline\/pdf\/JCS2016_terasaki_h.pdf."},{"key":"10.1016\/j.cardfail.2021.06.010_bib0023","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-172OT","article-title":"Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study. Sarcoidosis protocol","volume":"12","author":"Moller","year":"2015","journal-title":". Ann Am Thorac Soc"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0024","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function byechocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2020.08.013","article-title":"Clinical and imaging response to tumor necrosis factor alpha inhibitors in treatment of cardiac sarcoidosis: a multicenter experience","volume":"27","author":"Gilotra","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2016.09.023","article-title":"Myocardial blood flow and inflammatory cardiac sarcoidosis","volume":"10","author":"Kruse","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0027","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0028","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","article-title":"Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis","volume":"25","author":"Ning","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0029","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1183\/09031936.00156314","article-title":"Negative clinical trials in sarcoidosis: failed therapies or flawed study design?","volume":"44","author":"Moller","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0030","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1183\/09031936.00195010","article-title":"Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis","volume":"38","author":"Sahoo","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0031","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0032","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0735-1097(91)90750-4","article-title":"Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device","volume":"18","author":"Winters","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0033","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/clc.4960270409","article-title":"Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome","volume":"27","author":"Furushima","year":"2004","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0034","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0035","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.06.010_bib0036","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.semarthrit.2019.11.004","article-title":"TNF-alpha inhibition for the treatment of cardiac sarcoidosis","volume":"50","author":"Baker","year":"2020","journal-title":"Semin Arthritis Rheum"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421002463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421002463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:47:26Z","timestamp":1761029246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916421002463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1071916421002463"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.06.010","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Cardiac Sarcoidosis Using Mycophenolate Mofetil as a Steroid-Sparing Agent","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}